Cargando…
Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility
BACKGROUND: 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is a metabolic antagonist of COX-2, catalyzing the degradation of inflammation mediator prostaglandin E2 (PGE(2)) and other prostanoids. Recent studies have established the 15-PGDH gene as a colon cancer suppressor. METHODS: We evaluated 15...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661460/ https://www.ncbi.nlm.nih.gov/pubmed/23717544 http://dx.doi.org/10.1371/journal.pone.0064122 |
_version_ | 1782270678038216704 |
---|---|
author | Thompson, Cheryl L. Fink, Stephen P. Lutterbaugh, James D. Elston, Robert C. Veigl, Martina L. Markowitz, Sanford D. Li, Li |
author_facet | Thompson, Cheryl L. Fink, Stephen P. Lutterbaugh, James D. Elston, Robert C. Veigl, Martina L. Markowitz, Sanford D. Li, Li |
author_sort | Thompson, Cheryl L. |
collection | PubMed |
description | BACKGROUND: 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is a metabolic antagonist of COX-2, catalyzing the degradation of inflammation mediator prostaglandin E2 (PGE(2)) and other prostanoids. Recent studies have established the 15-PGDH gene as a colon cancer suppressor. METHODS: We evaluated 15-PDGH as a colon cancer susceptibility locus in a three-stage design. We first genotyped 102 single-nucleotide polymorphisms (SNPs) in the 15-PGDH gene, spanning ∼50 kb up and down-stream of the coding region, in 464 colon cancer cases and 393 population controls. We then genotyped the same SNPs, and also assayed the expression levels of 15-PGDH in colon tissues from 69 independent patients for whom colon tissue and paired germline DNA samples were available. In the final stage 3, we genotyped the 9 most promising SNPs from stages 1 and 2 in an independent sample of 525 cases and 816 controls (stage 3). RESULTS: In the first two stages, three SNPs (rs1365611, rs6844282 and rs2332897) were statistically significant (p<0.05) in combined analysis of association with risk of colon cancer and of association with 15-PGDH expression, after adjustment for multiple testing. For one additional SNP, rs2555639, the T allele showed increased cancer risk and decreased 15-PGDH expression, but just missed statistical significance (p-adjusted = 0.063). In stage 3, rs2555639 alone showed evidence of association with an odds ratio (TT compared to CC) of 1.50 (95% CI = 1.05–2.15, p = 0.026). CONCLUSIONS: Our data suggest that the rs2555639 T allele is associated with increased risk of colon cancer, and that carriers of this risk allele exhibit decreased expression of 15-PGDH in the colon. |
format | Online Article Text |
id | pubmed-3661460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36614602013-05-28 Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility Thompson, Cheryl L. Fink, Stephen P. Lutterbaugh, James D. Elston, Robert C. Veigl, Martina L. Markowitz, Sanford D. Li, Li PLoS One Research Article BACKGROUND: 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is a metabolic antagonist of COX-2, catalyzing the degradation of inflammation mediator prostaglandin E2 (PGE(2)) and other prostanoids. Recent studies have established the 15-PGDH gene as a colon cancer suppressor. METHODS: We evaluated 15-PDGH as a colon cancer susceptibility locus in a three-stage design. We first genotyped 102 single-nucleotide polymorphisms (SNPs) in the 15-PGDH gene, spanning ∼50 kb up and down-stream of the coding region, in 464 colon cancer cases and 393 population controls. We then genotyped the same SNPs, and also assayed the expression levels of 15-PGDH in colon tissues from 69 independent patients for whom colon tissue and paired germline DNA samples were available. In the final stage 3, we genotyped the 9 most promising SNPs from stages 1 and 2 in an independent sample of 525 cases and 816 controls (stage 3). RESULTS: In the first two stages, three SNPs (rs1365611, rs6844282 and rs2332897) were statistically significant (p<0.05) in combined analysis of association with risk of colon cancer and of association with 15-PGDH expression, after adjustment for multiple testing. For one additional SNP, rs2555639, the T allele showed increased cancer risk and decreased 15-PGDH expression, but just missed statistical significance (p-adjusted = 0.063). In stage 3, rs2555639 alone showed evidence of association with an odds ratio (TT compared to CC) of 1.50 (95% CI = 1.05–2.15, p = 0.026). CONCLUSIONS: Our data suggest that the rs2555639 T allele is associated with increased risk of colon cancer, and that carriers of this risk allele exhibit decreased expression of 15-PGDH in the colon. Public Library of Science 2013-05-22 /pmc/articles/PMC3661460/ /pubmed/23717544 http://dx.doi.org/10.1371/journal.pone.0064122 Text en © 2013 Thompson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Thompson, Cheryl L. Fink, Stephen P. Lutterbaugh, James D. Elston, Robert C. Veigl, Martina L. Markowitz, Sanford D. Li, Li Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility |
title | Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility |
title_full | Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility |
title_fullStr | Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility |
title_full_unstemmed | Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility |
title_short | Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility |
title_sort | genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661460/ https://www.ncbi.nlm.nih.gov/pubmed/23717544 http://dx.doi.org/10.1371/journal.pone.0064122 |
work_keys_str_mv | AT thompsoncheryll geneticvariationin15hydroxyprostaglandindehydrogenaseandcoloncancersusceptibility AT finkstephenp geneticvariationin15hydroxyprostaglandindehydrogenaseandcoloncancersusceptibility AT lutterbaughjamesd geneticvariationin15hydroxyprostaglandindehydrogenaseandcoloncancersusceptibility AT elstonrobertc geneticvariationin15hydroxyprostaglandindehydrogenaseandcoloncancersusceptibility AT veiglmartinal geneticvariationin15hydroxyprostaglandindehydrogenaseandcoloncancersusceptibility AT markowitzsanfordd geneticvariationin15hydroxyprostaglandindehydrogenaseandcoloncancersusceptibility AT lili geneticvariationin15hydroxyprostaglandindehydrogenaseandcoloncancersusceptibility |